Results 101 to 110 of about 47,842 (168)

Tumor cell ferroptosis in antitumor immunity and immunotherapy efficacy. [PDF]

J Immunother Cancer
Li S, Gajewski T.
europepmc   +1 more source

Disulfidptosis: A Metabolic Cell Death Mechanism with Therapeutic Potential in Cancer. [PDF]

Oncol Res
Zhao W, Wang Q, Zhang J.
europepmc   +1 more source

MYCN Amplification Drives Ferroptosis Susceptibility via Cysteine Metabolism in Retinoblastoma. [PDF]

Invest Ophthalmol Vis Sci
Chen Y, Xu H, Xiao L, Zhang Y, Gao Y, Man S, Wang D, Mou K, Huang Y, Yan N, Zhang M.   +10 more
europepmc   +1 more source

Inhibition of Low-Density Lipoprotein Oxidation by Cysteamine, Cystamine, Cysteine and Cystine at Lysosomal pH and pH 7.4. [PDF]

Antioxidants (Basel)
Parkes EJ, Cruz AM, Kaur A, Clark GR, Pulford TE, Ness C, Ahmad F, Wen Y, Leake DS.   +8 more
europepmc   +1 more source

Quantification of Single-Cell Cysteine Using an Electrochemical Nanosensor for Predicting Tumor Disulfidptosis Susceptibility. [PDF]

Adv Sci (Weinh)
Zhang C, Zhang X, Li S, Li Y, Yuan B, Zheng M, Zhang S, Yuan F, Jia M, Lu L, Zhou J, Zhang Z, Du X.   +12 more
europepmc   +1 more source

Fe₃O₄@MCM-41-Cystine-ZnCl₂ nanocomposite in deep eutectic solvent: a sustainable and scalable catalytic system for three-component synthesis of triarylpyridines. [PDF]

Sci Rep
Al Omari RH, Mohammadi R, Ganesan S, Al-Shaker H, Jayabalan K, Sharma R, Sinha A.   +6 more
europepmc   +1 more source

Advances in Pharmacological Treatments for Cystinosis: Cysteamine and Its Alternatives. [PDF]

ACS Pharmacol Transl Sci
Carneiro A, Jones DH.
europepmc   +1 more source

THE DEAMINIZATION OF CYSTINE

Journal of Biological Chemistry, 1930
openaire   +1 more source

Ginkgetin enhances the antitumor effect of Taxol on human breast cancer MCF-7 cells via ferroptosis mediated by the MDM2-p53-YAP1 axis. [PDF]

Sci Rep
Li G, Yan W, Peng X, Yin Z, Mahati S.
europepmc   +1 more source

Prevalence of Monogenic Aetiologies of Kidney Stone Disease in Selected and Unselected Kidney Stone Cohorts

Lovegrove C, Croghan S, Geraghty R, Mabillard H, Asaad W, Bull K, Holmes M, Furniss D, Rogers AG, Sayer JA, Howles SA.   +10 more
europepmc   +1 more source